Abstract: The disclosure is an engine simulation test device capable of realizing an ultrahigh compression temperature and pressure, belonging to the field of a diesel engine high-temperature and high-pressure system, solving the problems that the existing engine simulation test cannot achieve ultra-high compression temperature and pressure, and the temperature and pressure are not adjustable. It includes a compressed air inlet mechanism, a nitrogen gas inlet mechanism, a pressure stabilizing mechanism, a cyclic heating mechanism, an air inlet mechanism and a fast compressor mechanism.

Abstract: This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of metabolic disorders (e.g. Prader-Willi syndrome, metabolic syndrome, insulin resistance, impaired glucose tolerance, prediabetes, diabetes mellitus (e.g., type II diabetes mellitus), dysglycemia (e.g., hyperglycemia), obesity (e.g., obesity caused by Prader-Willi syndrome), increased adiposity, poor glycemic control, hyperphagia, impaired satiety, dyslipidemia (e.g., atherogenic dyslipidemia), hepatic steatosis (e.g., non-alcoholic fatty liver disease (e.g., non-alcoholic steatohepatitis))), psychiatric disorders (e.g., eating disorders (e.g., bulimia nervosa, binge eating disorder, night-time eating syndrome), substance related disorders (e.g., addiction disorders (e.g.

Abstract: This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of metabolic disorders (e.g. Prader-Willi syndrome, metabolic syndrome, insulin resistance, impaired glucose tolerance, prediabetes, diabetes mellitus (e.g., type II diabetes mellitus), dysglycemia (e.g., hyperglycemia), obesity (e.g., obesity caused by Prader-Willi syndrome), increased adiposity, poor glycemic control, hyperphagia, impaired satiety, dyslipidemia (e.g., atherogenic dyslipidemia), hepatic steatosis (e.g., non-alcoholic fatty liver disease (e.g., non-alcoholic steatohepatitis))), psychiatric disorders (e.g., eating disorders (e.g., bulimia nervosa, binge eating disorder, night-time eating syndrome), substance related disorders (e.g., addiction disorders (e.g.

Abstract: This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of metabolic disorders (e.g. Prader-Willi syndrome, metabolic syndrome, insulin resistance, impaired glucose tolerance, prediabetes, diabetes mellitus (e.g., type II diabetes mellitus), dysglycemia (e.g., hyperglycemia), obesity (e.g., obesity caused by Prader-Willi syndrome), increased adiposity, poor glycemic control, hyperphagia, impaired satiety, dyslipidemia (e.g., atherogenic dyslipidemia), hepatic steatosis (e.g., non-alcoholic fatty liver disease (e.g., non-alcoholic steatohepatitis))), psychiatric disorders (e.g., eating disorders (e.g., bulimia nervosa, binge eating disorder, night-time eating syndrome), substance related disorders (e.g., addiction disorders (e.g.

Abstract: The invention purifies desired polynucleotide samples by removing impurities resulting from biochemical reactions or physical manipulation, such as excess oligonucleotides, salt and protein after a polymerase chain reaction (PCR), or by selecting polynucleotide of desired sizes from a mixture of polynucleotides of different sizes resulting from polynucleotide fragmentation procedures. Desired polynucleotides bind reversibly to a solid surface such as magnetic micro-particles whose surfaces are coated with or without a functional group, such as a carboxyl group, during the removal process of impurity or polynucleotides of unintended sizes. The polynucleotides can be DNA, RNA or polyamide nucleic acids (PNAs). As a result, polynucleotides bound to the solid surface are purified or selected for desired sizes.

Abstract: An information transmission method includes: modulating, by a terminal device, encoded hybrid automatic repeat request (HARQ) information according to a codebook, to generate HARQ modulation symbols, where the HARQ modulation symbols include at least one non-zero HARQ modulation symbol and at least one zero HARQ modulation symbol, the codebook includes at least two code words, the code words are multi-dimensional complex vectors, and the code words are used to indicate a mapping relationship between a bit and at least two modulation symbols; and sending the HARQ modulation symbols to a network device.

Abstract: A method for determining a modulation and coding scheme is disclosed. The method is performed by a network device. The method includes: determining a quantity K of terminal devices that reuse a first time-frequency resource in a first time period to receive downlink data from the network device, where K?2; obtaining a channel quality indicator (CQI), where the CQI is determined according to a signal to interference plus noise ratio (SINR) of a channel and the quantity K of the terminal devices, where the channel is a channel based on the first time-frequency resource, and the channel is used to transmit downlink data between a first terminal device and the network device in the first time period; and determining a Modulation and Coding scheme (MCS) of the first terminal device according to the CQI.

Abstract: A quantizer includes: a quantizer capacitor having a first end and a second end; an input calculator that receives input voltages, sums the input voltages, and outputs the summed result to the first end of the quantizer capacitor; a scaler that receives reference voltages and a scale code, generates a scale voltage from the reference voltages depending on the scale code, and outputs the scale voltage to the second end of the quantizer capacitor; and a latch that stores an output voltage of the first end of the quantizer capacitor.

Abstract: A quantizer includes: a quantizer capacitor having a first end and a second end; an input calculator that receives input voltages, sums the input voltages, and outputs the summed result to the first end of the quantizer capacitor; a scaler that receives reference voltages and a scale code, generates a scale voltage from the reference voltages depending on the scale code, and outputs the scale voltage to the second end of the quantizer capacitor; and a latch that stores an output voltage of the first end of the quantizer capacitor.

Abstract: Embodiments of the present invention provide a data read/write method and apparatus, a storage device, and a computer system, so as to reduce completion time of a data read/write operation in a multi-core computer system. The method includes: determining, by a host device, N cores used for executing a target process, where the N cores are in a one-to-one correspondence with N execution threads included in the target process; grouping the N execution threads to determine M execution thread groups, and allocating an indication identifier to each execution thread group; and sending M data read/write instructions to a storage device, where each data read/write instruction includes an indication identifier of a corresponding execution thread group.

Abstract: A method for scheduling a terminal device comprises performing blind detection on N subframes by using at least one codebook and a pilot corresponding to the codebook, and determining, according to a blind detection result, a first pilot set corresponding to each codebook in each subframe, where correct terminal data cannot be obtained by performing blind detection by using a pilot in the first pilot set and a corresponding codebook. The method comprises determining, according to the first pilot set corresponding to each codebook, a second pilot set corresponding to each codebook, where a pilot in the second pilot set is a pilot that is in the first pilot set and that has already been sent by the terminal device, and determining a to-be-used transmission mode according to the second pilot set corresponding to each codebook in each subframe, where different transmission modes correspond to different spectrum multiplex rates.

Abstract: Embodiments relate to a data transmission method. A relay node receives information that is about an SCMA codebook used by the relay node and that is sent by a destination node. The relay node receives two or more source signals sent by two or more source nodes. The relay node performs network coding on the received two or more source signals. The relay node performs SCMA codebook mapping on a signal obtained after the network coding, so as to obtain at least two modulation symbols. The relay node sends to the destination node, the at least two modulation symbols obtained after the SCMA mapping.

Abstract: The present invention discloses an information transmission method, a terminal device, a network device, and an apparatus. The method includes: modulating, by a terminal device, encoded hybrid automatic repeat request (HARQ) information according to a codebook, to generate HARQ modulation symbols, where the HARQ modulation symbols include at least one non-zero HARQ modulation symbol and at least one zero HARQ modulation symbol, the codebook includes at least two code words, the code words are multi-dimensional complex vectors, and the code words are used to indicate a mapping relationship between a bit and at least two modulation symbols; sending the HARQ modulation symbols to a network device.

Abstract: A method for scheduling a terminal device comprises performing blind detection on N subframes by using at least one codebook and a pilot corresponding to the codebook, and determining, according to a blind detection result, a first pilot set corresponding to each codebook in each subframe, where correct terminal data cannot be obtained by performing blind detection by using a pilot in the first pilot set and a corresponding codebook. The method comprises determining, according to the first pilot set corresponding to each codebook, a second pilot set corresponding to each codebook, where a pilot in the second pilot set is a pilot that is in the first pilot set and that has already been sent by the terminal device, and determining a to-be-used transmission mode according to the second pilot set corresponding to each codebook in each subframe, where different transmission modes correspond to different spectrum multiplex rates.

Abstract: Embodiments relate to a data transmission method. A relay node receives information that is about an SCMA codebook used by the relay node and that is sent by a destination node. The relay node receives two or more source signals sent by two or more source nodes. The relay node performs network coding on the received two or more source signals. The relay node performs SCMA codebook mapping on a signal obtained after the network coding, so as to obtain at least two modulation symbols. The relay node sends to the destination node, the at least two modulation symbols obtained after the SCMA mapping.

Abstract: This invention relates to novel compounds according to Formula (III)(a) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), and to pharmaceutical compositions containing them.

Abstract: A method for determining a modulation and coding scheme is disclosed. The method is performed by a network device. The method includes: determining a quantity K of terminal devices that reuse a first time-frequency resource in a first time period to receive downlink data from the network device, where K?2; obtaining a channel quality indicator (CQI), where the CQI is determined according to a signal to interference plus noise ratio (SINR) of a channel and the quantity K of the terminal devices, where the channel is a channel based on the first time-frequency resource, and the channel is used to transmit downlink data between a first terminal device and the network device in the first time period; and determining a Modulation and Coding scheme (MCS) of the first terminal device according to the CQI.

Abstract: Embodiments of the present invention provide a data read/write method and apparatus, a storage device, and a computer system, so as to reduce completion time of a data read/write operation in a multi-core computer system. The method includes: determining, by a host device, N cores used for executing a target process, where the N cores are in a one-to-one correspondence with N execution threads included in the target process; grouping the N execution threads to determine M execution thread groups, and allocating an indication identifier to each execution thread group; and sending M data read/write instructions to a storage device, where each data read/write instruction includes an indication identifier of a corresponding execution thread group.

Abstract: This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.

Abstract: This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.